Risperdal Lawsuit Victory for State of Arkansas

An Arkansas jury has sided with the state in a potential $1,000,000,000 lawsuit against Johnson & Johnson and Janssen Pharmaceuticals, the manufacturers and distributors of the controversial drug Risperdal.
“Today, an Arkansas jury confirmed that Johnson & Johnson and Janssen Pharmaceuticals lied to patients and doctors because they cared more about profits than people. I am grateful for the jury’s verdict and its decision to hold the defendants accountable for their actions,” Arkansas Attorney General Dustin McDaniel said in a news release after the verdict was announced.
The Risperdal lawsuit was filed over concerns that the pharmaceutical companies concealed risks and adverse events associated with the anti-psychotic drug.